Skip to content

Hypnosis in Internal Medecine

Hypnose en médecine Interne

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04698824
Acronym
HypnoMedIn
Enrollment
70
Registered
2021-01-07
Start date
2021-06-30
Completion date
2021-10-31
Last updated
2021-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypnosis, Autoimmune Diseases, Medically Unexplained Symptoms

Keywords

internal medicine, survey, qualitative, impact of hypnosis

Brief summary

Description of the short and long-term impact of hypnosis sessions for patient having benefited from at least one hypnosis session in internal medicine at the french hospital Groupe Hospitalier Mutualiste de Grenoble, with the help of a qualitative survey made by phone.

Detailed description

The practice of hypnosis has experienced a recent boom in medicine, with a multiplication of its fields of action. Regarding internal medicine, the influence of the psyche on the immune system makes the use of hypnosis particularly relevant for autoimmune diseases. Medically unexplained symptoms (another important field of internal medicine) are also strongly psychosomatic and thus susceptible to hypnosis. The hypothesis is thus made that hypnosis can bring multiple benefits to internal medicine patients. The main objective of this study is to describe the short and long-term impact of hypnosis sessions for patient having benefited from at least one hypnosis session in internal medicine at the french hospital Groupe Hospitalier Mutualiste de Grenoble, with the help of a qualitative survey made by phone. Moreover retrospective medical data concerning these patients will be collected to determine their medical history, their main symptoms et reasons to use hypnosis.

Interventions

At least one session of hypnosis in the internal medicine unit at the hospital Groupe Hospitalier Mutualiste de Grenoble

Sponsors

Groupe Hospitalier Mutualiste de Grenoble
CollaboratorOTHER
University Hospital, Grenoble
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All consecutive patients who had at least one hypnosis session in internal medicine at the hospital Groupe Hospitalier Mutualiste de Grenoble between 08/28/2015 (date of the very first hypnosis consultation in internal medicine) and 03/17/2020 (date of confinement due to Covid19 in France)

Exclusion criteria

* Patient who had a hypnosis session, but who is not followed for a pathology in internal medicine or in internal medicine with a pneumological orientation

Design outcomes

Primary

MeasureTime frameDescription
Description of the short and long-term impact of hypnosis sessions thanks to a qualitative phone surveyAssessed only once. Phone call will be performed between march 2021 and June 2021Improvement in symptoms and quality of life, assessed thanks to a qualitative phone survey by 5-levels Likert scales

Secondary

MeasureTime frameDescription
Assessment of the reasons for patient satisfaction / dissatisfactionAssessed only once. Phone call will be performed between march 2021 and June 2021Qualitative description by an open question in the phone survey
Description of the characteristics of these patients and of the hypnosis sessionsAt inclusionPatients'characteristics described in medical records

Contacts

Primary ContactMaxime LUGOSI, PhD
mlugosi@chu-grenoble.fr04 76 76 37 07
Backup ContactMélanie ARNAUD
marnaud3@chu-grenoble.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026